IL17A and pulmonary emphysema: IL-17A, a cytokine that plays a central role in amplifying inflammatory cascades by inducing a variety of chemokines and cytokines, has also been reported to contribute to the development of emphysema [52], [53] and to the immunopathology following influenza infections [54].